BioSpace News Archive

Avinger, Inc. today announced that it will release its financial results for the fourth quarter and full year 2022 after the close of trading on Wednesday, March 15, 2023.

Kartos Therapeutics, Inc. today announced that Dr. Srdan (Serge) Verstovsek, MD, PhD, has been named Chief Medical Officer (CMO).

Surgalign Holdings, Inc. announced that Medical City Frisco, a world-class acute care hospital in Frisco, TX and part of HCA Healthcare, is the latest medical facility to clinically use its HOLO Portal Surgical Navigation System.

Milestone Scientific Inc. today announced that its CompuFlo® Epidural System has been granted registration with the U.S. Government’s System for Award Management (SAM).

PharmAla Biotech Holdings Inc., a biotechnology company focused on the research, development, and manufacturing of MDXX class molecules are pleased to announce that PharmAla has been named the exclusive MDMA supplier to Awakn LS Europe Holdings Limited.

Anixa Biosciences, Inc. today announced that its CEO, Dr. Amit Kumar , will provide a corporate presentation on the company.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in three upcoming investor conferences.

Visus Therapeutics Inc. today announced that Ben Bergo, co-founder and chief executive officer, will attend TD Cowen’s 43rd Annual Health Care Conference on March 6-8, 2023 in Boston.

RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of solid tumors, today is reporting its financial results for the year ended December 31, 2022, and a pipeline update including the status of the interim analysis of for the Company’s Phase III TIGeR-PaC clinical trial.

Jaguar Health, Inc. today announced that Lisa Conte, the Company’s founder, president, and CEO, is scheduled to present at the BioTrinity 2023 conference in London on Tuesday, April 25, 2023 during the R&D Spotlight session on Rare Diseases.